This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. Container Closure Systems. A container closure system protects the product from environmental conditions, safeguarding a product’s purity, strength, safety and efficacy.
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. Quality in terms of number of defective items, packaging and labelling, quality management system certification, research, development, and innovation.
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing decision. Role of freeze-drying systems in the pharmaceutical industry The pharmaceutical freeze-drying market is highly governed by stringent standards and laws.
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, businessdevelopment managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
The companies offer various solid dose products and services including, but not limited to, formulation and analytical development, manufacturing capabilities, technology transfer and scale-up, quality and regulatory support, commercial manufacturing, packaging, and warehousing.
Packaging. • Test method development. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, businessdevelopment managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector.
Sweet also explored different development techniques with minimal processing. While it embodies all the properties of table sugar, Cambya contains no added sucrose or artificial additives. To ensure high solubility and blending capacity for easy integration into food and beverage products, B.T.
Data has long been incorporated into drug packaging to accomplish these goals, but only to a partial degree with embossed lot numbers, expiry dates and even Braille identification in addition to linear bar codes. For example, Turkey will require track and trace by 1 January 2009 and California is requiring the technology by 1 January 2011.
They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through businessdevelopment activities. 2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19.
Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent businessdevelopment. BusinessDevelopment/Other Developments. In the second quarter of 2021, the company recognized acquired in-process research and development charges of $25.0
At its Investor Update, GSK announced a package of new financial outlooks and ambitions. The £33 billion sales ambition is before any significant revenue contribution from early-stage pipeline assets or any contribution from businessdevelopment. Outlooks for New GSK represent a step-change in growth and performance.
Corporate and BusinessDevelopment Update. The Company’s 2020 financial guidance does not assume the completion of any significant businessdevelopment transactions not completed as of the date of this press release. (4). government.
Management believes that measuring revenue rates on a comparable pro forma basis is an appropriate way for investors to best understand the underlying performance of the business. The replay will also be available through [link] or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 8970168.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content